HBC — Hofseth Biocare ASA Share News
0.000.00%
Last trade - 00:00- NOK513.85m
- NOK746.89m
- NOK256.34m
Brief: Hofseth Biocare Q2 EBITDA Loss Narrows To NOK 8.4 Million
Brief: Hofseth Biocare Completes Oversubscribed Private Placement
Brief: Hofseth Biocare Says Private Placement Of New Shares For Proceeds Of About NOK 118 Mln
Brief: Hofseth Biocare Signs Letter Of Intent With Garden Of Life In US
Brief: HBC Says On 24 May 2019, 3.4 Mln Shares Were Sold By Bonafide Global Fish Fund, Purchased By Bonafide Investment Fund - Best Catches I
Brief: Hofseth Biocare Q1 Operating Revenues Of NOK 14.7 Mln VS NOK 14.8 Mln
Brief: Hofseth Biocare Q4 Operational Loss Widens To NOK 18.7 Mln
Brief: Hofseth Biocare Introduces Nøre Nutrition As Its New Sales Company
Brief: Hofseth Biocare Q3 EBITDA Loss Widens To NOK 14.7 Mln
Brief: Hofseth Biocare: Subsequent Offering Raised Gross Proceeds Of About NOK 14.9 Mln
Brief: Hofseth Biocare Q2 Operating Loss at NOK 18.3 Million
Brief: Hofseth Biocare: Subsequent Offering Of Up To 8.9 Million New Shares
Brief: Hofseth Biocare announces net cash proceeds from private placement of NOK 57.4 mln
Brief: Hofseth Biocare Launches Private Placement, Consolidates Its Factories, Improves Production Process And Reduces Its Production Costs
Brief: Hofseth Biocare Q1 EBITDA Swings To Loss Of NOK 14.9 Million
Brief: Hofseth Biocare Q4 Operating Revenue Up At Nok 26.4 Million
Brief: Hofseth Biocare preliminary Total Revenues In Q4 at about NOK 26 mln
Brief: Hofseth Biocare Q3 EBITDA loss narrows to NOK 6.3 mln
Brief: Hofseth Biocare signs a NOK 35 mln financing agreement